Quoin Pharmaceuticals, Ltd. (QNRX)
↓ Download CSV- Sector Manufacturing
- Incorporated L3
Key ratios (FY2025)
-120.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $0 | $0 | — |
| Net Income | -$15.80M | -$8.96M | -$8.69M | -$9.38M | -$21.46M | -$2.10M | -$1.56M | — |
| EPS (Diluted) | — | — | — | — | $-0.01 | $-0.70 | $-0.52 | — |
| Total Assets | $20.39M | $15.71M | $12.17M | $14.46M | $9.36M | $1.38M | — | — |
| Total Liabilities | $7.27M | $6.50M | $6.51M | $7.05M | $8.70M | $7.99M | — | — |
| Shareholders' Equity | $13.12M | $9.20M | $5.66M | $7.41M | $657.0K | -$6.61M | -$4.51M | -$2.95M |
| Cash & Equivalents | $3.82M | $3.62M | $2.40M | $2.86M | $7.48M | $323.8K | — | — |
| Operating Cash Flow | -$13.54M | -$7.86M | -$7.86M | -$8.48M | -$5.72M | -$1.34M | -$1.30M | — |
| Shares Outstanding | 52.44M | 8.95M | 987.2K | 403.9K | 3.35B | 1.20B | — | — |